Olefsky J M
Diabetes Care. 1981 Mar-Apr;4(2):244-7. doi: 10.2337/diacare.4.2.244.
Insulin binding to receptors, insulin action, and cellular insulin metabolism were studied using biosynthetic human insulin (BHI). The results demonstrated that this insulin preparation binds to receptors with full binding potency and also exerts normal biologic activity to stimulate adipocyte glucose oxidation and glucose transport. Furthermore, following initial binding to adipocyte receptors, BHI is internalized and degraded in a manner indistinguishable from purified pork insulin (PPI). Thus, these results demonstrate that BHI has full biologic activity, is metabolized normally, and should produce the full insulin effect when administered to diabetic patients.
使用生物合成人胰岛素(BHI)对胰岛素与受体的结合、胰岛素作用及细胞胰岛素代谢进行了研究。结果表明,这种胰岛素制剂以完全的结合能力与受体结合,并且还发挥正常的生物学活性来刺激脂肪细胞葡萄糖氧化和葡萄糖转运。此外,在最初与脂肪细胞受体结合后,BHI以内化并降解的方式,与纯化猪胰岛素(PPI)无法区分。因此,这些结果表明,BHI具有完全的生物学活性,代谢正常,并且在给糖尿病患者使用时应能产生完整的胰岛素效应。